Mar 12, 2019 / 01:20PM GMT
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD and Senior Research Analyst
We'll get started. Very happy to have Pfizer with us this year at the Cowen conference. Representing the company, Chris Boshoff, who's Senior Vice President and Chief Development Officer in the Oncology business; as well as Andy Schmeltz, who is Global President of Oncology.
Oncology is such an important business to Pfizer, and it's one part of what we think is an emerging new product story. So it's great to have you here to walk us through the many exciting developments in the company.
So they're going to present just a few slides to set the stage, and then we'll dive right into questions.
Andy Schmeltz - Pfizer Inc. - Global President, Oncology
Great. Thanks, Steve. Chris and I are very happy to be here. if you want to cue the slides up, perhaps?
Okay. So maybe make a few opening remarks and then jump in.
We're very proud in Pfizer Oncology of the strong growth trajectory over the past several years. In fact, our compound
Pfizer Inc at Cowen Health Care Conference Transcript
Mar 12, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers